{"id":60391,"date":"2024-11-25T19:04:19","date_gmt":"2024-11-25T18:04:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/"},"modified":"2024-11-25T19:04:19","modified_gmt":"2024-11-25T18:04:19","slug":"vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/","title":{"rendered":"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis"},"content":{"rendered":"
\n

HAYWARD, Calif.–(BUSINESS WIRE)–#EmployeeBenefits<\/a>–During a landmark webinar<\/a> this week, VIVIO, a Public Benefit Corporation, announced PrecisionCare One\u2122<\/b>, an extension of its proven open-market specialty drug management platform to include all drugs. This builds on VIVIO\u2019s prior success in managing complex specialty medications across pharmacy and medical benefits, where its clinical-first approach has delivered cost-effective outcomes in oncology, rheumatology, multiple sclerosis, HIV, and other specialized therapeutic areas.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nPharmacy Benefit Managers (PBMs) have long positioned themselves as cost-reduction champions. Instead, their opaque practices have systematically inflated medication costs through hidden fees, rebate manipulation, and anti-competitive pricing strategies. These expensive intermediaries have siphoned billions from healthcare, failing patients and employers alike.<\/p>\n

\n“We’ve demonstrated that combining deep clinical expertise with open market economics works for the most complex medications. Now we’re expanding this model for all drugs,” said Pramod John, VIVIO’s CEO<\/b>. “It isn’t that we need better PBMs; we just don’t need their model anymore.”<\/p>\n

\nThe expanded platform includes VIVIO’s latest innovation: a comprehensive clinical management program for GLP-1 medications. This program addresses one of healthcare’s fastest-growing cost drivers and applies the same rigorous, evidence-based approach that has long distinguished VIVIO’s specialty drug management.<\/p>\n

\nAs open markets revolutionized retail, transportation, travel, and other industries, VIVIO is applying these same transformative principles to healthcare. “Buying healthcare can be as straightforward as purchasing any other good or service,” John continued. “We’re fixing the broken system by eliminating discount guarantees, exclusive formularies, and rebate schemes that artificially inflate prices, reduce competition, and compromise health outcomes.”<\/p>\n

\nMark Cuban<\/b>, who co-presented at the webinar, emphasized the urgency of this mission: “Nobody looks at healthcare and says, ‘This is an efficient market.’ What VIVIO and Cost Plus Drugs are doing can fundamentally reshape healthcare for the entire country.”<\/p>\n

\nVIVIO’s first PrecisionCare One customer, Lake County Schools, embodies the frustration with traditional PBM models. “We were tired of playing the rebate shell game,” said Director of Risk Management<\/b> Robert Oyer<\/b>. “The only way to know if we are saving real dollars is to have verifiable unit costs.”<\/p>\n

\nVIVIO’s approach doesn’t eliminate nuance\u2014it eliminates waste. By applying open market principles and providing complete visibility into costs and decision-making, the platform replaces unnecessary complexity with intelligent simplicity while maintaining the sophisticated data-driven clinical oversight that has been the hallmark of VIVIO’s specialty drug management success.<\/p>\n

\nPrecisionCare One is more than just a new product\u2014it’s a plug-and-play solution built on open-market principles and data-driven clinical models designed to redefine healthcare economics. Extending its transformation of the specialty drug space, VIVIO is now poised to revolutionize the entire pharmacy benefits industry with a common-sense procurement approach to drugs\u2014a long overdue change.<\/p>\n

Contacts<\/b> <\/p>\n

\nVIVIO
\n
T. J. Tedesco
\n
301-404-2244
\n
ttedesco@viviohealth.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HAYWARD, Calif.–(BUSINESS WIRE)–#EmployeeBenefits–During a landmark webinar this week, VIVIO, a Public Benefit Corporation, announced PrecisionCare One\u2122, an extension of its proven open-market specialty drug management platform to include all drugs. This builds on VIVIO\u2019s prior success in managing complex specialty medications across pharmacy and medical benefits, where its clinical-first approach has delivered cost-effective outcomes in … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60391","6":"format-standard","7":"category-industry"},"yoast_head":"\nVIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HAYWARD, Calif.–(BUSINESS WIRE)–#EmployeeBenefits–During a landmark webinar this week, VIVIO, a Public Benefit Corporation, announced PrecisionCare One\u2122, an extension of its proven open-market specialty drug management platform to include all drugs. This builds on VIVIO\u2019s prior success in managing complex specialty medications across pharmacy and medical benefits, where its clinical-first approach has delivered cost-effective outcomes in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-25T18:04:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20241125851504\/en\/2314402\/22\/Pramod_John_VIVIO_CEO-2024.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis\",\"datePublished\":\"2024-11-25T18:04:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/\"},\"wordCount\":480,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241125851504\\\/en\\\/2314402\\\/22\\\/Pramod_John_VIVIO_CEO-2024.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/\",\"name\":\"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241125851504\\\/en\\\/2314402\\\/22\\\/Pramod_John_VIVIO_CEO-2024.jpg\",\"datePublished\":\"2024-11-25T18:04:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241125851504\\\/en\\\/2314402\\\/22\\\/Pramod_John_VIVIO_CEO-2024.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241125851504\\\/en\\\/2314402\\\/22\\\/Pramod_John_VIVIO_CEO-2024.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/","og_locale":"en_US","og_type":"article","og_title":"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis - Pharma Trend","og_description":"HAYWARD, Calif.–(BUSINESS WIRE)–#EmployeeBenefits–During a landmark webinar this week, VIVIO, a Public Benefit Corporation, announced PrecisionCare One\u2122, an extension of its proven open-market specialty drug management platform to include all drugs. This builds on VIVIO\u2019s prior success in managing complex specialty medications across pharmacy and medical benefits, where its clinical-first approach has delivered cost-effective outcomes in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/","og_site_name":"Pharma Trend","article_published_time":"2024-11-25T18:04:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20241125851504\/en\/2314402\/22\/Pramod_John_VIVIO_CEO-2024.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis","datePublished":"2024-11-25T18:04:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/"},"wordCount":480,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241125851504\/en\/2314402\/22\/Pramod_John_VIVIO_CEO-2024.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/","url":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/","name":"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241125851504\/en\/2314402\/22\/Pramod_John_VIVIO_CEO-2024.jpg","datePublished":"2024-11-25T18:04:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20241125851504\/en\/2314402\/22\/Pramod_John_VIVIO_CEO-2024.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20241125851504\/en\/2314402\/22\/Pramod_John_VIVIO_CEO-2024.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vivio-extends-open-market-specialty-drug-platform-to-solve-our-pbm-crisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"VIVIO Extends Open Market Specialty Drug Platform to Solve Our PBM Crisis"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60391"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60391\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}